热尼斯坦和瓦纳达特通过醇敏感机制在老鼠中不同调节皮质GABAA受体/ATPase活动和行为
Sergey A Menzikov1, Danila M Zaichenko1, Aleksey A Moskovtsev1
1Institute of General Pathology and Pathophysiology, 8, Baltiyskaya St., Moscow 125315, Russia.
International journal of molecular sciences
|June 26, 2025
概括
热尼斯坦和瓦纳达特对GABAA受体和ATPase活性表现出相反的作用,影响神经元离子运输. 热尼斯坦减轻了诱导的不良影响,突出了它们在突触可塑性调节中的相互作用.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- GABAA受体介导离子流,但被动和活性运输之间的协调仍然不清楚.
- 氨酸激酶和酸酶抑制剂调节神经元功能,影响离子稳态.
研究的目的:
- 在GABAAR介导的离子变化和ATPase活性中研究基因斯坦和瓦纳的作用.
- 阐明被动和活性离子运输协调的分子机制.
主要方法:
- 在老鼠皮层神经元和HEK 293FT细胞中进行光测量.
- 评估的GABAAR介导的化物和碳酸变化.
- 评估ATPase活性和基因斯坦,瓦纳和的影响.
主要成果:
- 热尼斯坦抑制了被动的GABAAR化物流入和化物ATPase活性.
- 瓦纳达特抑制了化物,碳酸盐ATPase活性和碳酸盐恢复.
- 醇逆转了阻断剂效应;基因斯坦在老鼠中减轻了醇诱导的不良影响.
结论:
- 基因斯坦和瓦纳在GABAAR/ATPase功能中具有相反的作用,调节二碳酸盐依赖的运输.
- 这些系统在突触可塑性调节中充当可两性化的元素.
- 在受体结合部位表现出基尼斯坦,瓦纳和之间的相互作用.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.7K
Activation and Inactivation of G Proteins
7.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.7K
GPCR Desensitization
6.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.6K


